AB
HZNP

Amalgamated Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Amalgamated Bank’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,658
Closed -$2.97M – 3032
2023
Q3 		$2.97M Buy
25,658
+1,686
+7% +$181K 0.03% 702
2023
Q2 		$2.47M Sell
23,972
-1,179
-5% -$124K 0.02% 800
2023
Q1 		$2.75M Buy
25,151
+401
+2% +$44.3K 0.02% 743
2022
Q4 		$2.82M Sell
24,750
-43
-0.2% -$3.57K 0.03% 762
2022
Q3 		$1.53M Sell
24,793
-1,626
-6% -$114K 0.01% 952
2022
Q2 		$2.11M Buy
26,419
+4,324
+20% +$409K 0.02% 846
2022
Q1 		$2.33M Sell
22,095
-47
-0.2% -$4.58K 0.02% 870
2021
Q4 		$2.39M Sell
22,142
-4,656
-17% -$508K 0.02% 859
2021
Q3 		$2.94M Sell
26,798
-2,100
-7% -$218K 0.02% 766
2021
Q2 		$2.71M Sell
28,898
-6,244
-18% -$575K 0.02% 836
2021
Q1 		$3.23M Sell
35,142
-3,183
-8% -$269K 0.12% 133
2020
Q4 		$2.8M Buy
38,325
+4
+0% +$297 0.11% 153
2020
Q3 		$2.98M Buy
38,321
+1,347
+4% +$92.7K 0.13% 131
2020
Q2 		$2.06M Sell
36,974
-4,189
-10% -$179K 0.1% 171
2020
Q1 		$1.22M Sell
41,163
-681
-2% -$23K 0.03% 533
2019
Q4 		$1.51M Buy
41,844
+4,168
+11% +$128K 0.03% 624
2019
Q3 		$1.03M Buy
37,676
+429
+1% +$11.1K 0.02% 732
2019
Q2 		$896K Buy
37,247
+9,760
+36% +$248K 0.02% 794
2019
Q1 		$726K Buy
27,487
+3,251
+13% +$77K 0.02% 832
2018
Q4 		$474K Buy
+24,236
New +$475K 0.01% 949
2018
Q3 		– Sell
-25,270
Closed -$418K – 1716
2018
Q2 		$418K Buy
25,270
+3,711
+17% +$56.6K 0.01% 1130
2018
Q1 		$306K Sell
21,559
-361
-2% -$5.33K 0.01% 1202
2017
Q4 		$320K Buy
21,920
+1,607
+8% +$22.6K 0.01% 1231
2017
Q3 		$258K Sell
20,313
-398
-2% -$5.06K 0.01% 1309
2017
Q2 		$246K Buy
20,711
+943
+5% +$11.7K 0.01% 1309
2017
Q1 		$292K Sell
19,768
-25
-0.1% -$405 0.01% 1151
2016
Q4 		$320K Buy
19,793
+2,727
+16% +$49.5K 0.01% 1097
2016
Q3 		$309K Buy
17,066
+22
+0.1% +$430 0.02% 1003
2016
Q2 		$393K Buy
+17,044
New +$276K 0.02% 849

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Amalgamated Bank's HZNP Position: Q4 2023 in Review

Amalgamated Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,658 shares — an estimated $2.97M sold.

Amalgamated Bank first reported a position in HZNP in Q2 2016 and held it in 29 quarters. The position peaked at $3.23M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Amalgamated Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Amalgamated Bank sold 25,658 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.97M.
  • Amalgamated Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 29 quarters.
  • Amalgamated Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.23M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Amalgamated Bank's 13F filing for Q4 2023, filed 6 Feb 2024.